UNHD trade ideas
UNH earningsUnited health Group (UNH) earnings are on Friday, July 14th, 2023, at 5:55am. United health Group (UNH) reported Q1 March 2023 earnings of 6.26 per share on revenue of 91.9 billion. The consensus earnings estimate was 6.24 per share on revenue of 89.8 billion. Revenue grew 14.7% on a year-over-year basis. The company said it expects 2023 earnings of 24.50 to 25.00 per share. The company's previous guidance was earnings of 24.40 to 24.90 per share and the current consensus earnings estimate is 24.91 per share for the year ending December 31, 2023.
I'm posting this as a long because of the entry price, risk : reward setup today on Monday 7/10/23. UNH has been trading in a wide sideways range in 2023.
2023
high = 537
low = 445
Q2 June 2023 Consensus:
EPS = 6.03
Revenue = 90.97 B
PE = 21.1
Options data:
7/14 expiry
Put Volume Total 1,323
Call Volume Total 2,131
Put/Call Volume Ratio 0.62
Put Open Interest Total 15,222
Call Open Interest Total 8,357
Put/Call Open Interest Ratio 1.82
7/21 expiry
Put Volume Total 453
Call Volume Total 769
Put/Call Volume Ratio 0.59
Put Open Interest Total 15,911
Call Open Interest Total 26,227
Put/Call Open Interest Ratio 0.61
8/18 expiry
Put Volume Total 912
Call Volume Total 952
Put/Call Volume Ratio 0.96
Put Open Interest Total 13,545
Call Open Interest Total 11,440
Put/Call Open Interest Ratio 1.18
UNH UnitedHealth Group Incorporated Options Ahead of EarningsIf you haven`t sold UNH here:
or here:
Then analyzing the options chain of UNH UnitedHealth Group Incorporated prior to the earnings report this week,
I would consider purchasing the 460usd strike price Calls with
an expiration date of 2024-1-19,
for a premium of approximately $36.25.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking forward to read your opinion about it.
UNITED HEALTH On the 1D MA50 but only buy under this condition.United Health is having an incredible price jump today with the price hitting the 1D MA50 for the first time in one month and the 1D timeframe attempting to get out of its neutrality (RSI = 52.965, MACD = -5.780, ADX = 33.018). This state shows that we don't have a confirmed buy signal yet, that will only come if the 1D candle closes over the 1D MA50. If not, a pull back to the bottom of the ten month Channel Down.
The 1D RSI is also inside a Channel Down, a breakout there would also be a buy signal. So if the candle closes above the 1D MA50 we will buy and aim at the top of the Channel Down (TP = 512.50) expecting the whole rally to complete a +15% rise. If rejected we will buy near the bottom of the Channel Down and target again its top near the 0.786 Fibonacci leve (TP = 508.00). That is where the previous LH was formed.
## If you like our free content follow our profile to get more daily ideas. ##
## Comments and likes are greatly appreciated. ##
Top up UNHHitting the bottom of the channel coinciding Fib 0.618 on a weekly chart.
MA150 (blue line) seems to have a good support resume in the past, and should be a good inidcator of able to hold. Bounce after earnings tomorrow? Who knows but definitely a
good opportuinity to accumulate healtcare stock while they are still lack behind of the tech stocks.
UnitedHealth Group Incorporated (UNH) Even though the share price of UnitedHealth Group Incorporated (symbol ‘UNH’) kicked off the second quarter with a rally, we witnessed a rather strong correction in mid-April that’s still in effect today. The company is expected to report quarterly earnings to 30 June 2023 on Friday, 14 July, before markets open. The consensus EPS for the quarter is $6.04 against $5.57 from the same quarter last year.
Antreas Themistokleous at Exness: “Even though the company managed to recover some of its losses at the beginning of the second quarter, those losses were significant, hitting the low levels seen at the end of the first quarter. Its current ratio was at 81% as of the end of March 2023, meaning UnitedHealth is not able to cover its short term liabilities with the current assets it holds. The total assets outweigh total liabilities at a ratio of around 1.43:1 which is not ideal.”
Technical analysis shows the price found sufficient support on the lower of the Bollinger bands last week, since correcting to the upside and entering a range in the last 4 or 5 sessions. The Stochastic oscillator is near the extreme overbought level, indicating a possible drop in the near short term. This is reinforced by the recent crossing of the 50-day moving average below the 100-day moving average.
The price of $464.60 is a strong technical support since it corresponds to the 38.2% weekly Fibonacci retracement level, while $490 marks technical resistance since it consists of the area just below the moving averages and is also slightly below the 23.6% weekly Fibonacci retracement level.
Is this the moment UNH finally breaks down? NYSE:UNH
UnitedHealth Group Inc (UNH) is one of the largest health care companies in the US, providing health insurance, health care services, and pharmacy benefits. The stock has been in a strong uptrend since March 2020, reaching an all-time high of $558.10 on October 31, 2022. However, since then, the stock has been showing signs of weakness and may be on the verge of a major breakdown.
Technical Analysis
Looking at the daily chart of UNH, we can see that the stock has broken a critical support zone of $476, which was the previous resistance level in July and August 2022. This zone also coincides with the 200-day moving average (MA), which is a widely followed indicator of long-term trend. The break below this zone indicates that the bulls have lost control and the bears are taking over.
The stock is currently retesting the $476 zone as resistance, which is a common phenomenon after a breakout. If the stock fails to reclaim this zone and closes below it, it would confirm the breakdown and open the door for further downside. The next support levels to watch are $450, which is the 50% Fibonacci retracement level of the March 2020 to October 2022 rally, and $420, which is the 61.8% Fibonacci retracement level and the previous support level in May 2022.
The technical indicators also support the bearish scenario. The MACD histogram has turned negative and crossed below the zero line, indicating a loss of momentum and a shift in trend. The RSI has fallen below 50 and is approaching the oversold territory, indicating a strong selling pressure. The volume has also increased on the downside, suggesting that more sellers are joining the market.
Conclusion
UNH has broken a critical support zone of $476 and is retesting it as resistance. If the stock fails to close above this zone, it would confirm the breakdown and signal a potential reversal of the long-term uptrend. The technical indicators are also bearish and point to more downside ahead. The next support levels to watch are $450 and $420.
UNH UnitedHealth Group Incorporated Double TopA double top is one of the most bearish technical reversal patterns.
A Double Top Bearish Chart Pattern forms after an asset reaches a high price two consecutive times.
After applying the Elliot Waves Pattern on UNH UnitedHealth Group, we have 2 price targets: $459 and $396.
Looking forward to read your opinion about it.
UNH UnitedHealth Group Incorporated Options Ahead Of EarningsIf you haven`t sold the Double Top:
Then looking at the UNH UnitedHealth Group Incorporated options chain ahead of earnings , i would buy the HKEX:520 strike price Calls with
2023-4-21 expiration date for about
$6.20 premium.
If the options turn out to be profitable Before the earnings release, i would sell at least 50%.
Looking forward to read your opinion about it.
United Health Earnings BeatOn Friday 14th April 2023 UnitedHealth Group reported full year and fourth quarter 2022 results reflecting broad-based growth at Optum and UnitedHealthcare.
Revenues of $324.2 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare
Cash Flows from Operations were $26.2 Billion or 1.3x Net Income
Full Year and Fourth Quarter Net Earnings were $21.18 and $5.03 Per Share
Full Year and Fourth Quarter Adjusted Net Earnings were $22.19 and $5.34 Per Share
UnitedHealth Group affirmed the 2023 growth and performance objectives established at its November 29th Investor Conference, including revenues of HKEX:357 billion to HKEX:360 billion, net earnings of $23.15 to $23.65 per share, adjusted net earnings of $24.40 to $24.90 per share and cash flows from operations of HKEX:27 billion to HKEX:28 billion.
UnitedHealth Group share outlook before the earningsShares in UnitedHealth Group Incorporated (symbol ‘UNH’) have been trading in a bearish movement throughout the first quarter of 2023. The company is expected to report its earnings for the fiscal quarter ending March 2023 on Friday 14th of April. The consensus EPS is $6,25 compared to the result for the same quarter last year of $5,49.
‘The last recording we had in regards to the company’s current ratio for the last quarter in 2022 was 77%. This indicates that the company does not have the ability to use its current assets to adequately cover its current liabilities. With a low dividend yield of less than 1.5% and a payout ratio of around 30% the company does not hold the title of an “exciting/attractive” selection in terms of returns.‘ said Antreas Themistokleous, an analyst at Exness ‘ Although the company’s technical details might not be that appealing it is still one of the biggest players in the health insurance industry and therefore still attracting investors attention.’
On the technical side the price has been trading in a declining channel for the first quarter of the year with a valid break above only in the last session. The Bollinger bands are expanding indicating volume building up while the following sessions are important to see if the price will move back into the channel or if the bullish correction will hold strong. The 50 day moving average is still trading well below the 1oo day moving average showing that the overall bearish movement is still valid for the time being while the Stochastic oscillator is moving towards the extreme overbought levels.